201 related articles for article (PubMed ID: 8701976)
1. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.
Zhou X; Stemme S; Hansson GK
Am J Pathol; 1996 Aug; 149(2):359-66. PubMed ID: 8701976
[TBL] [Abstract][Full Text] [Related]
2. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
3. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
4. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
Davenport P; Tipping PG
Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
[TBL] [Abstract][Full Text] [Related]
5. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
Buono C; Pang H; Uchida Y; Libby P; Sharpe AH; Lichtman AH
Circulation; 2004 Apr; 109(16):2009-15. PubMed ID: 15096453
[TBL] [Abstract][Full Text] [Related]
6. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
Afek A; Harats D; Roth A; Keren G; George J
Exp Mol Pathol; 2004 Jun; 76(3):219-23. PubMed ID: 15126104
[TBL] [Abstract][Full Text] [Related]
8. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
10. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
[TBL] [Abstract][Full Text] [Related]
11. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-15 in mouse and human atherosclerotic lesions.
Wuttge DM; Eriksson P; Sirsjö A; Hansson GK; Stemme S
Am J Pathol; 2001 Aug; 159(2):417-23. PubMed ID: 11485899
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti A; Kaveri S; Caligiuri G; Bariéty J; Hansson GK
J Clin Invest; 1998 Sep; 102(5):910-8. PubMed ID: 9727059
[TBL] [Abstract][Full Text] [Related]
14. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhou J; Lhoták S; Hilditch BA; Austin RC
Circulation; 2005 Apr; 111(14):1814-21. PubMed ID: 15809369
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
[TBL] [Abstract][Full Text] [Related]
16. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
17. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
Chen X; Oppenheim JJ; Howard OM
J Leukoc Biol; 2005 Jul; 78(1):114-21. PubMed ID: 15845645
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
Caligiuri G; Nicoletti A; Poirier B; Hansson GK
J Clin Invest; 2002 Mar; 109(6):745-53. PubMed ID: 11901183
[TBL] [Abstract][Full Text] [Related]
19. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
[TBL] [Abstract][Full Text] [Related]
20. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
Olofsson PS; Söderström LA; Wågsäter D; Sheikine Y; Ocaya P; Lang F; Rabu C; Chen L; Rudling M; Aukrust P; Hedin U; Paulsson-Berne G; Sirsjö A; Hansson GK
Circulation; 2008 Mar; 117(10):1292-301. PubMed ID: 18285570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
